NASDAQ:IIN

Delisted

Intricon Stock News

Healthcare > Medical - Instruments & Supplies

Buy IIN

*Your capital is at risk

$24.24

+0 (+0%)

At Close: Aug 23, 2022

Intricon Reports Third Quarter 2019 Results

09:13pm, Monday, 04'th Nov 2019

ARDEN HILLS, Minn., Nov. 04, 2019 -- IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices,.

IntriCon Q3 EPS $(0.03) May Not Compare It $0.01 Estimate, Sales $26.9M Miss $27.65M Estimate

12:00am, Monday, 04'th Nov 2019

IntriCon to Announce —…–9 Third-Quarter Results on Monday, November 4, —…–9

12:00am, Monday, 21'st Oct 2019

Dougherty Earlier Assumed IntriCon at Buy, Announced $34 Price Target

12:00am, Friday, 20'th Sep 2019

IntriCon Corporation (IIN) CEO Mark Gorder on Q2 2019 - Earnings Call Transcript

12:00am, Sunday, 11'th Aug 2019

IntriCon Reaffirms FY19 Sales Guidance $115M-$117.5M vs $116.3M Estimate

12:00am, Tuesday, 06'th Aug 2019

Analysts Estimate IntriCon (IIN) to Report a Decline in Earnings: What to Look Out for

12:00am, Tuesday, 30'th Jul 2019

Analysts Recommend Buying These — Falling Knives

12:00am, Sunday, 28'th Jul 2019

List of Companies Reaching Yearly Lows Tuesday

12:00am, Tuesday, 23'rd Jul 2019

55 Biggest Movers From Friday

12:00am, Monday, 22'nd Jul 2019

41 Stocks Moving In Friday's Mid-Day Session

12:00am, Friday, 19'th Jul 2019

IntriCon shares are trading lower after the company reported preliminary Q2 sales below analyst estimates; the company also cut its FY19 sales guidance below analyst estimates.

12:00am, Thursday, 18'th Jul 2019

Earnings Preview: IntriCon (IIN) Q2 Earnings Expected to Decline

12:00am, Wednesday, 17'th Jul 2019

Intricon Stock News

Intricon Reports Third Quarter 2019 Results

IntriCon Q3 EPS $(0.03) May Not Compare It $0.01 Estimate, Sales $26.9M Miss $27.65M Estimate

IntriCon to Announce —…–9 Third-Quarter Results on Monday, November 4, —…–9

Dougherty Earlier Assumed IntriCon at Buy, Announced $34 Price Target

IntriCon Corporation (IIN) CEO Mark Gorder on Q2 2019 - Earnings Call Transcript

IntriCon Reaffirms FY19 Sales Guidance $115M-$117.5M vs $116.3M Estimate

Analysts Estimate IntriCon (IIN) to Report a Decline in Earnings: What to Look Out for

Analysts Recommend Buying These — Falling Knives

List of Companies Reaching Yearly Lows Tuesday

55 Biggest Movers From Friday

41 Stocks Moving In Friday's Mid-Day Session

IntriCon shares are trading lower after the company reported preliminary Q2 sales below analyst estimates; the company also cut its FY19 sales guidance below analyst estimates.

Earnings Preview: IntriCon (IIN) Q2 Earnings Expected to Decline

IntriCon Enters Distribution Agreement With Puretone; Puretone To Distribute Co.'s Hearing Aids

IntriCon closing UK unit

Top Fintech Company